Search results
Merck & Co Inc (MRK) Sits And Waits For Direction At $131.30 Price – Stocks Register
Stocks Register· 5 days agoMerck & Co Inc (NYSE:MRK) at last check was buoying at $131.30 on Thursday, May 23 with a rise of 0.15% from its closing price on previous day. Taking a look at stock we notice ...
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Pharmaceutical Technology via Yahoo Finance· 5 days agoMerck executive board chair and CEO Belén Garijo stated: “This strategic acquisition is a further...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 2 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 4 days agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
Nvidia's split of soaring stock could boost retail investor appeal, Dow chances
Reuters via Yahoo News· 4 days agoNvidia shares were soaring 10% on Thursday afternoon after the company announced a 10-for-one stock...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 4 days agoAmong abstracts announced yesterday by the American Society of Clinical Oncology (ASCO) is positive...
TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders
Morningstar· 22 hours agoPharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME),a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 3 days agoThursday, Merus N.V. (NASDAQ:MRUS) announced the publication of an abstract regarding petosemtamab...
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 5 days agoEisai announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical...
Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
Zacks via Yahoo Finance· 13 hours agoData from an earlier cut-off date shows that treatment with Merus' (MRUS) combination therapy...